Short description
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease.
Description
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease in the very early stages. Alzheimer's Disease affects over 26 million people world-wide and is a growing condition as people live longer. There is currently no cure for Alzheimer's Disease, but there are large international initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo Fisher Scientific) to support Pharmaceutical and Biotechnology companies developing novel therapeutics.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Manchester, Manchester, United Kingdom, Europe
Founded on
January 1, 2004
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccess, Nopepepe, Noaccessforu, Blurry Noaccess, Noaccessforu, Noway Youcantaccess, Noaccess, No Way, Nopepepe, Noaccessforu, Cannot Access, Noway Youcantaccess, Cannot Access, Cannot Access, Cannot Access, Noaccess
Sign in for full access
Founders
Zsuzsanna Nagy